2003, Number 1
<< Back Next >>
Acta Med 2003; 1 (1)
Acute Myocardial Infarct. Initial Treatment
Espinosa FR, Pavia LAA
Language: Spanish
References: 9
Page: 45-48
PDF size: 56.93 Kb.
Text Extraction
No abstract
REFERENCES
Herlitz J, Blohm M, Hartford M, et al. Delay time in suspected acute myocardial infarction and the importance of its modification. Clin Cardiol 1989; 12: 370-275.
National Heart, Lung and Blood Institute. 911 rapid identification and treatment of acute myocardial infarction. NIH Publication. Public Health Service, National Institutes of Health. Bethesda, MD, USA: Department of Health and Human Services; 1994: 94-99.
National Heart, Lung and Blood Institute. Patient/bystander recognition and action: rapid identification and treatment of acute myocardial infarction. No. 93. National Attack Alert Program (NHAAP). NIH Publication. Bethesda, MD, USA: National Institutes of Health; 1993: 117-121.
Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention Trial. JAMA 1993; 270: 1211-1217.
Yusuf S, Fox KAA, Tognoni G, et al. Effects of clopedigrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation (CURE). N Engl J Med 2001; 345: 494-502.
Fibrinolytic Therapy Trials (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results for all randomized trials of more than 1,000 patients. Lancet 1994; 343: 311-317.
Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction Second International Study of Infarct Survival (ISIS-2) Collaborative Group. Lancet 1988; 2: 349-355.
Pavia A, Espinosa R. Bloqueo de las glicoproteínas IIb/IIIa en los síndromes coronarios agudos. Rev Mex Aterosc Prev Cardiovasc 2002; 5(1): 16-20.
Espinosa R, Pavia A. Bloqueadores de los receptores plaquetarios de las glicoproteínas IIb/IIIa en la cardiopatía isquémica. An Med Asoc Hosp ABC 2000; 45: 200-204.
Full text